InsidersTradesSigma
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Hung Yung Lai, Executive. Director active across 1 company, notably Dawnrays Pharmaceutical (Holdings) Ltd.. Cumulatively, 9 reports have been recorded. Activity tracked since 30 March 2026. The latest transaction was disclosed on 3 September 2026 (Purchase). Regulator: HKEX. All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Hung Yung Lai is a Dirigeant and a director of Dawnrays Pharmaceutical (Holdings) Ltd. The declarant has 8 filings in total, and the 8 sampled filings cover purchases for EUR 43012, with no sales, between 2026-04-01 and 2026-06-29.